GSK appoints Emma Walmsley as chief executive officer

06:51 EDT 23 Sep 2016 | PharmaBiz

GSK has appointed Emma Walmsley as chief executive officer. Emma currently CEO of GSK's Consumer Healthcare division, and will succeed Andrew Witty as GSK CEO, when he retires on 31 March 2017.

Original Article: GSK appoints Emma Walmsley as chief executive officer


More From BioPortfolio on "GSK appoints Emma Walmsley as chief executive officer"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...